Skip to main content
. 2015 Nov 27;14(4):254–259. doi: 10.5114/pm.2015.55887

Tab. I.

Studies on circulating miRNAs as potential biomarkers of ovarian cancer

Author/Reference no. Year Ovarian cancer type Control Type of sample Up-regulated Down-regulated
Taylor and Gercel-Taylor [50] 2008 Serous Benign ovarian tumors Exosomal serum miRNA miR-21, miR-141, miR-200a, miR-200b, mir-200c, miR-203, miR-205, miR-214
Resnick et al. [48] 2008 Generally epithelial ovarian cancer Healthy controls Serum miRNA miR-21, miR-92, miR-93, miR-126, miR-29a miR-155, miR-127, miR-99b
Kan et al. [51] 2012 Serous (high grade) Healthy controls Serum miRNA miR-200a, miR-200b, miR-200c
Chung et al. [52] 2013 Serous Healthy controls Serum miRNA miR-132, miR-26a, Let-7b, mir-145
Suryawanshi et al. [46] 2013 Endometrioid/Serous Healthy controls/Endometriosis Plasma miRNA miR-16, miR-21, miR-191, miR-4284
Ji et al. [53] 2014 Generally epithelial ovarian cancer Healthy controls/Benign ovarian tumors Serum miRNA miR-22, miR-93
Shapira et al. [54] 2014 Serous Healthy controls/Benign ovarian tumors Plasma miRNA miR-106b, miR-126, miR-150, miR-17, miR-20a, and miR-92a